Invesco’s Performant Healthcare Inc PHLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-34,126
| Closed | -$264K | – | 3896 |
|
|
2025
Q3 | $264K | Buy |
34,126
+526
| +2% | +$3.35K | ﹤0.01% | 3469 |
|
|
2025
Q2 | $134K | Buy |
33,600
+4,682
| +16% | +$13.3K | ﹤0.01% | 3606 |
|
|
2025
Q1 | $85.6K | Sell |
28,918
-1,487
| -5% | -$3.85K | ﹤0.01% | 3650 |
|
|
2024
Q4 | $91.8K | Buy |
30,405
+1,293
| +4% | +$4.44K | ﹤0.01% | 3635 |
|
|
2024
Q3 | $109K | Sell |
29,112
-43,830
| -60% | -$150K | ﹤0.01% | 3606 |
|
|
2024
Q2 | $212K | Sell |
72,942
-501
| -0.7% | -$1.44K | ﹤0.01% | 3609 |
|
|
2024
Q1 | $216K | Sell |
73,443
-5,589
| -7% | -$16K | ﹤0.01% | 3617 |
|
|
2023
Q4 | $247K | Buy |
79,032
+46,789
| +145% | +$123K | ﹤0.01% | 3491 |
|
|
2023
Q3 | $72.9K | Hold |
32,243
| – | – | ﹤0.01% | 3766 |
|
|
2023
Q2 | $87.1K | Buy |
+32,243
| New | +$93.3K | ﹤0.01% | 3753 |
|
|
2020
Q4 | – | Sell |
-9,762,903
| Closed | -$9.16M | – | 3833 |
|
|
2020
Q3 | $9.16M | Buy |
9,762,903
+31,370
| +0.3% | +$20.2K | ﹤0.01% | 1696 |
|
|
2020
Q2 | $6.35M | Sell |
9,731,533
-508,592
| -5% | -$350K | ﹤0.01% | 1867 |
|
|
2020
Q1 | $9.22M | Sell |
10,240,125
-1,612
| -0% | -$1.65K | ﹤0.01% | 1569 |
|
|
2019
Q4 | $10.4M | Hold |
10,241,737
| – | – | ﹤0.01% | 1742 |
|
|
2019
Q3 | $11.3M | Hold |
10,241,737
| – | – | ﹤0.01% | 1681 |
|
|
2019
Q2 | $10.8M | Hold |
10,241,737
| – | – | ﹤0.01% | 1719 |
|
|
2019
Q1 | $21.2M | Sell |
10,241,737
-6,260
| -0.1% | -$13.1K | 0.01% | 1195 |
|
|
2018
Q4 | $23.1M | Hold |
10,247,997
| – | – | 0.01% | 1090 |
|
|
2018
Q3 | $21.7M | Sell |
10,247,997
-4,830
| -0% | -$10.1K | 0.01% | 1224 |
|
|
2018
Q2 | $22M | Buy |
10,252,827
+111,090
| +1% | +$290K | 0.01% | 1179 |
|
|
2018
Q1 | $30.4M | Buy |
10,141,737
+50,154
| +0.5% | +$131K | 0.01% | 961 |
|
|
2017
Q4 | $16.7M | Buy |
10,091,583
+1,247,838
| +14% | +$2.25M | 0.01% | 1301 |
|
|
2017
Q3 | $16.1M | Sell |
8,843,745
-32,275
| -0.4% | -$61.3K | 0.01% | 1302 |
|
|
2017
Q2 | $18.6M | Buy |
8,876,020
+32,275
| +0.4% | +$72.8K | 0.01% | 1228 |
|
|
2017
Q1 | $25.9M | Sell |
8,843,745
-763,485
| -8% | -$1.48M | 0.01% | 1071 |
|
|
2016
Q4 | $22.6M | Sell |
9,607,230
-100
| -0% | -$321 | 0.01% | 1111 |
|
|
2016
Q3 | $28.3M | Hold |
9,607,330
| – | – | 0.01% | 1014 |
|
|
2016
Q2 | $15.6M | Sell |
9,607,330
-16,004
| -0.2% | -$27.2K | 0.01% | 1244 |
|
|
2016
Q1 | $16.4M | Sell |
9,623,334
-35,293
| -0.4% | -$61.2K | 0.01% | 1212 |
|
|
2015
Q4 | $17.3M | Sell |
9,658,627
-106,212
| -1% | -$242K | 0.01% | 1216 |
|
|
2015
Q3 | $23.6M | Sell |
9,764,839
-81,675
| -0.8% | -$238K | 0.01% | 1059 |
|
|
2015
Q2 | $31.9M | Sell |
9,846,514
-1,691
| -0% | -$5.26K | 0.01% | 1029 |
|
|
2015
Q1 | $33.5M | Buy |
9,848,205
+24,706
| +0.3% | +$125K | 0.01% | 985 |
|
|
2014
Q4 | $65.3M | Buy |
9,823,499
+3,811,426
| +63% | +$27.9M | 0.03% | 673 |
|
|
2014
Q3 | $48.6M | Buy |
6,012,073
+3,771,568
| +168% | +$36.3M | 0.02% | 787 |
|
|
2014
Q2 | $22.6M | Buy |
2,240,505
+34,837
| +2% | +$318K | 0.01% | 1148 |
|
|
2014
Q1 | $20M | Buy |
+2,205,668
| New | +$19.2M | 0.01% | 1186 |
|
Other funds holding PHLT
Invesco's PHLT Position: Q4 2025 in Review
Invesco sold out of Performant Healthcare Inc (PHLT) in Q4 2025, closing a stake of 34,126 shares — an estimated $264K sold.
Invesco first reported a position in PHLT in Q1 2014 and held it in 37 quarters. The position peaked at $65.3M in Q4 2014. 1 fund tracked by Wall St. Rank holds PHLT as of Q4 2025.
- Invesco reported no remaining Performant Healthcare Inc position as of Q4 2025 after selling out during the quarter.
- Invesco sold 34,126 Performant Healthcare Inc shares in Q4 2025, an estimated $264K.
- Invesco first reported a position in Performant Healthcare Inc in Q1 2014 and held it in 37 quarters.
- Invesco's Performant Healthcare Inc position peaked at $65.3M in Q4 2014.
- 1 fund tracked by Wall St. Rank held Performant Healthcare Inc as of Q4 2025.
Based on Invesco's 13F filing for Q4 2025, filed 19 Feb 2026.